These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35645805)

  • 81. Propensity Score-Matched Analysis to Identify Pathways Associated with Loss of Sodium Iodide Symporter in Papillary Thyroid Cancer.
    Lee F; Kuo CY; Tsai CH; Cheng SP
    Curr Issues Mol Biol; 2022 Mar; 44(4):1488-1496. PubMed ID: 35723359
    [TBL] [Abstract][Full Text] [Related]  

  • 82. NADPH Oxidase NOX4 Is a Critical Mediator of BRAF
    Azouzi N; Cailloux J; Cazarin JM; Knauf JA; Cracchiolo J; Al Ghuzlan A; Hartl D; Polak M; Carré A; El Mzibri M; Filali-Maltouf A; Al Bouzidi A; Schlumberger M; Fagin JA; Ameziane-El-Hassani R; Dupuy C
    Antioxid Redox Signal; 2017 May; 26(15):864-877. PubMed ID: 27401113
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells.
    Yu KH; Youn H; Song MG; Lee DS; Chung JK
    Nucl Med Mol Imaging; 2012 Dec; 46(4):239-46. PubMed ID: 24900070
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
    Zhang M; Guo R; Xu H; Zhang M; Li B
    Nucl Med Commun; 2011 Jul; 32(7):605-10. PubMed ID: 21471848
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
    Bauriaud-Mallet M; Vija-Racaru L; Brillouet S; Mallinger A; de Medina P; Rives A; Payre B; Poirot M; Courbon F; Silvente-Poirot S
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105390. PubMed ID: 31170473
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.
    Huang R; Zhao Z; Ma X; Li S; Gong R; Kuang A
    Cancer Gene Ther; 2011 Feb; 18(2):144-52. PubMed ID: 21037556
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells.
    Li W; Ain KB
    Endocr Relat Cancer; 2010 Jun; 17(2):383-98. PubMed ID: 20228127
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of BRAF(V600E) mutation on Na(+)/I(-) symporter expression in papillary thyroid carcinoma.
    Dong H; Shen WZ; Yan YJ; Yi JL; Zhang L
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):77-81. PubMed ID: 26838744
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma: a pilot study.
    Almeida LS; Araújo MC; Zantut-Wittmann DE; Assumpção LV; Souza TF; Silva CM; Argenton JL; Santos AO; Mengatti J; Ramos CD; Etchebehere EC
    Nucl Med Commun; 2018 May; 39(5):441-450. PubMed ID: 29543624
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy.
    Liu J; Liu Y; Lin Y; Liang J
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):215-225. PubMed ID: 31565873
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
    D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
    J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling.
    Feng F; Yehia L; Ni Y; Chang YS; Jhiang SM; Eng C
    Cancer Res; 2018 Nov; 78(21):6121-6133. PubMed ID: 30217930
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance.
    Gao H; Bai P; Xiao L; Shen M; Yu Q; Lei Y; Huang W; Lin X; Zheng X; Wei T; Jiang Y; Ye F; Bu H
    J Biol Chem; 2020 Jul; 295(31):10726-10740. PubMed ID: 32532820
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
    Spitzweg C; Joba W; Morris JC; Heufelder AE
    Thyroid; 1999 Aug; 9(8):821-30. PubMed ID: 10482376
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A novel gene signature related to focal adhesions for distinguishing and predicting the prognosis of lung squamous cell carcinoma.
    Hui G; Xie Y; Niu L; Liu J
    Front Med (Lausanne); 2023; 10():1284490. PubMed ID: 38259849
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study.
    Mozzicafreddo M; Benfaremo D; Paolini C; Agarbati S; Svegliati Baroni S; Moroncini G
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298573
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Machine learning in TCM with natural products and molecules: current status and future perspectives.
    Ma S; Liu J; Li W; Liu Y; Hui X; Qu P; Jiang Z; Li J; Wang J
    Chin Med; 2023 Apr; 18(1):43. PubMed ID: 37076902
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    Yu X; Zhu X; Zhang L; Qin JJ; Feng C; Li Q
    Front Pharmacol; 2022; 13():883581. PubMed ID: 35645805
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Redifferentiation of radioiodine-refractory thyroid cancers.
    Buffet C; Wassermann J; Hecht F; Leenhardt L; Dupuy C; Groussin L; Lussey-Lepoutre C
    Endocr Relat Cancer; 2020 May; 27(5):R113-R132. PubMed ID: 32191916
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Molecular basis and targeted therapies for radioiodine refractory thyroid cancer.
    Yu Q; Zhang X; Li L; Zhang C; Huang J; Huang W
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):279-289. PubMed ID: 35950297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.